Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Immunovant Inc (IMVT)

Immunovant Inc (IMVT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,014,291
  • Shares Outstanding, K 114,999
  • Annual Sales, $ 0 K
  • Annual Income, $ -107,430 K
  • 60-Month Beta 0.80
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.42
Trade IMVT with:

Options Overview

Details
  • Implied Volatility 84.85%
  • Historical Volatility 45.37%
  • IV Percentile 11%
  • IV Rank 8.83%
  • IV High 182.26% on 12/04/20
  • IV Low 75.41% on 08/27/21
  • Put/Call Vol Ratio 0.53
  • Today's Volume 98
  • Volume Avg (30-Day) 381
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 18,197
  • Open Int (30-Day) 26,568

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.26
  • Number of Estimates 3
  • High Estimate -0.26
  • Low Estimate -0.26
  • Prior Year -0.25
  • Growth Rate Est. (year over year) -4.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.29 +20.99%
on 08/20/21
9.32 -5.42%
on 09/03/21
+0.97 (+12.36%)
since 08/17/21
3-Month
6.68 +32.04%
on 08/03/21
11.61 -24.03%
on 06/28/21
-2.32 (-20.83%)
since 06/17/21
52-Week
6.68 +32.04%
on 08/03/21
53.75 -83.59%
on 11/18/20
-29.61 (-77.05%)
since 09/17/20

Most Recent Stories

More News
Immunovant Appoints Renee Barnett as Chief Financial Officer

-- Ms. Barnett brings a wealth of financial experience to Immunovant

IMVT : 8.82 (+3.89%)
Immunovant, Inc. (IMVT) Up 9.3% Since Last Earnings Report: Can It Continue?

Immunovant, Inc. (IMVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IMVT : 8.82 (+3.89%)
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Immunovant, Inc. for Potential Breach of Fiduciary Duty Claims

NEW YORK, NY / ACCESSWIRE / September 8, 2021 / Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Immunovant, Inc. .

IMVT : 8.82 (+3.89%)
Precarious Market Action

Precarious Market Action

LOW : 209.03 (+0.26%)
TJX : 70.41 (-0.10%)
ARKK : 121.50 (+2.47%)
TSLA : 759.49 (+0.33%)
NDAQ : 192.90 (-1.29%)
MRNA : 430.05 (-2.41%)
PFE : 43.89 (-1.30%)
IMVT : 8.82 (+3.89%)
AAP : 205.80 (-0.91%)
Immunovant (IMVT) Reports Wider-Than-Expected Loss in Q1

Immunovant's (IMVT) earnings miss estimates in first-quarter fiscal 2022 (ended Jun 30, 2021). Focus remains on lead pipeline candidate IMVT-1401.

JNJ : 164.75 (-0.28%)
RGEN : 306.90 (+2.34%)
SPRO : 19.15 (+0.52%)
IMVT : 8.82 (+3.89%)
Immunovant Reports Financial Results for the Quarter Ended June 30, 2021

Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, today reported financial results for its fiscal first quarter...

IMVT : 8.82 (+3.89%)
Immunovant to Report Financial Results for Quarter Ended June 30, 2021

Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, today announced that it will host a conference call and...

IMVT : 8.82 (+3.89%)
Immunovant Receives $200 Million Strategic Investment from Roivant Sciences

Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, today announced that it has received a $200 million strategic...

IMVT : 8.82 (+3.89%)
Immunovant, Inc. (IMVT) Up 6.6% Since Last Earnings Report: Can It Continue?

Immunovant, Inc. (IMVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IMVT : 8.82 (+3.89%)
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Immunovant, Inc. (IMVT) and Encourages Stockholders to Contact the Firm

PHILADELPHIA, PA / ACCESSWIRE / June 2, 2021 / Kaskela Law LLC announces that it is investigating Immunovant, Inc. (Nasdaq: IMVT) on behalf of the Company's stockholders.

IMVT : 8.82 (+3.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Immunovant Inc. is a clinical-stage biopharmaceutical company focused on autoimmune diseases. The company's product candidate consists of IMVT-1401 which is a novel, fully human monoclonal antibody targeting the neonatal Fc receptor which is in clinical stage. Immunovant Inc. is based in New York, United...

See More

Key Turning Points

3rd Resistance Point 9.48
2nd Resistance Point 9.19
1st Resistance Point 9.00
Last Price 8.82
1st Support Level 8.52
2nd Support Level 8.23
3rd Support Level 8.04

See More

52-Week High 53.75
Fibonacci 61.8% 35.77
Fibonacci 50% 30.22
Fibonacci 38.2% 24.66
Last Price 8.82
52-Week Low 6.68

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar